These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10891378)

  • 21. Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells.
    Chambers KA; Parks RJ; Angel JB
    Clin Exp Immunol; 2004 Aug; 137(2):329-40. PubMed ID: 15270850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts.
    Butcher HL; Kennette WA; Collins O; Zalups RK; Koropatnick J
    J Pharmacol Exp Ther; 2004 Aug; 310(2):589-98. PubMed ID: 15039454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells.
    Rohr O; Marban C; Aunis D; Schaeffer E
    J Leukoc Biol; 2003 Nov; 74(5):736-49. PubMed ID: 12960235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
    Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
    J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dialyzable leukocyte extracts (DLE) and inosine on stimulated lymphocytes.
    Komatsu F
    Bull Tokyo Med Dent Univ; 1989 Sep; 36(3):35-40. PubMed ID: 2632132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-induced leukocyte extract reduces HIV replication and TNF secretion.
    Fernández-Ortega C; Dubed M; Ramos Y; Navea L; Alvarez G; Lobaina L; López L; Casillas D; Rodríguez L
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1075-81. PubMed ID: 15541398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression.
    Qu D; Li C; Sang F; Li Q; Jiang ZQ; Xu LR; Guo HJ; Zhang C; Wang JH
    Sci Rep; 2016 Oct; 6():34532. PubMed ID: 27698388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different fractions of dialyzable leukocyte extract--transfer factor--on the chemiluminescence of human phagocytes.
    Sipka S; Schröder I; Brazsnikova NA
    Allergol Immunopathol (Madr); 1987; 15(3):143-4. PubMed ID: 3661353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-kB and HIV.
    Hennighausen L; Furth PA
    Nature; 1990 Jan; 343(6255):218-9. PubMed ID: 2405277
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV. Tampering with transcription.
    Nabel GJ
    Nature; 1991 Apr; 350(6320):658. PubMed ID: 2023629
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidermodysplasia verruciformis: response to therapy with dialyzable leukocyte extract (transfer factor) derived from household contacts.
    Vasily DB; Miller OF; Fudenberg HH; Goust JM; Wilson GB
    J Clin Lab Immunol; 1984 May; 14(1):49-57. PubMed ID: 6086930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of in vitro HIV infection by dialysable leucocyte extracts.
    Fernandez-Ortega C; Dubed M; Ruibal O; Vilarrubia OL; Menéndez de San Pedro JC; Navea L; Ojeda M; Araña MJ
    Biotherapy; 1996; 9(1-3):33-40. PubMed ID: 8993755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and cost effective cell-based assay for Dialyzed Leukocyte Extract (DLE)-induced Jurkat cells proliferation under azathioprine treatment.
    Cardoso FM; Tomkova M; Petrovajova D; Bubanova M; Ragac O; Hornakova T
    J Pharm Biomed Anal; 2017 May; 138():100-108. PubMed ID: 28189890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract.
    Rebulla P; Tedesco F; Radillo O; Battaglioli M; Boeri M; Rosso di San Secondo VE; Sirchia G
    Transfusion; 1991; 31(3):218-21. PubMed ID: 2003323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.
    Lara HH; Ixtepan-Turrent L; Garza-Treviño EN; Badillo-Almaraz JI; Rodriguez-Padilla C
    BMC Res Notes; 2011 Nov; 4():474. PubMed ID: 22044844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of delayed-type hypersensitivity in antigen-primed guinea pigs by human dialyzable leukocyte extract. Chromatographic and enzymatic characterization of the active principle.
    Ashorn RG; Marnela KM; Uotila A; Krohn KJ
    Acta Pathol Microbiol Immunol Scand C; 1982 Dec; 90(6):331-7. PubMed ID: 6763449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialyzable leukocyte extract stimulates cAMP in T gamma lymphocytes.
    Herlin T; Jensen JR; Thestrup-Pedersen K; Zachariae H
    Allergy; 1981 Jul; 36(5):337-43. PubMed ID: 6274217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dialyzable leukocyte extract: partial purification of low-molecular-weight factors suppressing and enhancing lymphocyte transformation.
    Rosso di San Secondo VE; Lugaro G; Sirchia G
    J Exp Pathol; 1987; 3(4):425-7. PubMed ID: 3454803
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity.
    Schroder I; Rovensky J
    Allergol Immunopathol (Madr); 1982; 10(3):171-6. PubMed ID: 7148610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.